Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly claims another head-to-head victory over Lantus in PhIII diabetes showdown
Fierce Biotech
Thursday, September 4, 2014 - 9:20am
tags:
Eli Lilly, Sanofi, Lantus, diabetes, basal insulin peglispro
Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists
Forbes
Thursday, September 4, 2014 - 8:29am
tags:
Piramal Healthcare, Exelixis, Novo Nordisk, R&D
Eisai Sells U.S. Rights to Zonegran
Drug Discovery and Development
Thursday, September 4, 2014 - 8:08am
tags:
Zonegran, Eisai, Concordia Pharmaceuticals
Doctors urge caution on Novartis' heart failure drug
Pharmaphorum
Thursday, September 4, 2014 - 8:06am
tags:
Novartis, heart failure, LCZ696
Simple Math Shows Ampio Knee Arthritis Drug is No Better Than Saline
TheStreet.com
Thursday, September 4, 2014 - 8:04am
tags:
knee arthritis, Ampio Pharmaceuticals, Ampion
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status
Yahoo/Zacks.com
Thursday, September 4, 2014 - 8:01am
tags:
Arena Pharmaceuticals, APD811, orphan drugs, PAH, pulmonary arterial hypertension
Wockhardt Comeback Sets Up Drugmaker as Target: Real M&A
Bloomberg
Thursday, September 4, 2014 - 7:57am
tags:
Wockhardt, M&A, India, Lupin, Mylan Labs, Actavis, Teva Pharmaceutical
Merck KGaA in Deal with S-TARget, Allergy Pipeline in Focus
Yahoo/Zacks.com
Thursday, September 4, 2014 - 7:56am
tags:
Merck KGaA, S-TARget, Allergopharma
J&J to Accelerate Ebola Vaccine Development
Bloomberg
Thursday, September 4, 2014 - 7:54am
tags:
ebola virus, JNJ, vaccines, Bavarian Nordic
Top 5 Performing Biotech Stocks Of 2014
Yahoo/Benzinga
Thursday, September 4, 2014 - 7:53am
tags:
biotech, Bluebird Bio, Puma Biotechnology, Tekmira, Amicus Therapeutics, Achillion
FDA: Little evidence to support testosterone drugs
Yahoo/AP
Wednesday, September 3, 2014 - 10:18pm
tags:
FDA, testosterone, Androgel, Fortesta, Eli Lilly, AbbVie, Endo Health Solutions, Upsher-Smith
AMA Bemoans CMS Sunshine Data Problems: ‘It’s Hard to Unring the Bell’
WSJ Pharmalot
Wednesday, September 3, 2014 - 10:13pm
tags:
AMA, Physician Payment Sunshine Act
Roche CEO Schwan took a hands-on approach negotiating $8.3B InterMune buyout
Fierce Biotech
Wednesday, September 3, 2014 - 10:12pm
tags:
Roche, Pharma CEOs, Severin Schwan, M&A, InterMune
J&J Unit Ran ‘Amok’ Marketing Pinnacle Hips, Jury Told
Bloomberg
Wednesday, September 3, 2014 - 5:25pm
tags:
JNJ, DePuy, Pinnacle Hip, hip implants
Roche to slash Spanish jobs in response to price controls
Pharma Times
Wednesday, September 3, 2014 - 5:23pm
tags:
Roche, layoffs, Spain
Google, AbbVie announce research partnership
Marketwatch
Wednesday, September 3, 2014 - 2:20pm
tags:
Google, AbbVie, Calico, R&D
Breast cancer: GE Healthcare wins pivotal FDA approval for 3D breast imaging
Mass Device
Wednesday, September 3, 2014 - 11:29am
tags:
breast cancer, GE Healthcare, FDA, SenoClaire, 3D imaging, devices
Feds pledge up to $42M to hit the gas on Mapp's Ebola drug
Fierce Biotech
Wednesday, September 3, 2014 - 10:43am
tags:
Mapp Biopharmaceutical, ebola virus, ZMapp
GSK's new Boston collaboration chief goes 'anti-pharma' as he prowls for partners
Fierce Biotech
Wednesday, September 3, 2014 - 10:40am
tags:
GSK, Boston, R&D
Feds: AIT's Evans 'unjustly enriched' himself in sale to employees
Indianapolis Business Journal, IN
Wednesday, September 3, 2014 - 10:29am
tags:
AIT Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.